Samir Parekh MD

Department of Medicine
Associate Professor

(404) 778-3986

Overview

Dr. Parekh serves as director of Hepatology Clinical Operations at The Emory Clinic. He completed his internal medicine residency followed by fellowships in gastroenterology and transplant hepatology at Emory University. He then joined the Emory hepatology faculty in 2007 and shortly after established Emorys first board accredited transplant hepatology fellowship,which he currently serves as Fellowship Program Director. Dr. Parekh earned a Certificate of Added Qualification in Transplant Hepatology in 2010.

Academic Appointment

Associate Professor of Medicine, Department of Medicine, Emory University School of Medicine
Distinguished Physician, Emory University School of Medicine
Associate Program Director, Division of Digestive Diseases and The Emory Transplant Center, Emory University School of Medicine

Education

Degrees

Doctor of Medicine from Medical College of Ohio
Bachelor of Science from Pennsylvania State University

Research

Publications

Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies.
Open Forum Infect Dis Volume: 9 Page(s): ofac171
06/01/2022 Authors: Figueiredo JC; Hirsch FR; Kushi LH; Nembhard WN; Crawford JM; Mantis N; Finster L; Merin NM; Merchant A; Reckamp KL
Classic Autoimmune Liver Disorders and Celiac Hepatitis.
Clin Liver Dis (Hoboken) Volume: 17 Page(s): 347 - 352
05/01/2021 Authors: Amir M; Parekh SM
ACUTE HEPATITIS E IN A STEM CELL TRANSPLANT PATIENT ON MAINTENANCE CHEMOTHERAPY
Volume: 72 Page(s): 617A - 617A
11/01/2020 Authors: Bloch J; Thuy-Van H; Parekh S
Transmission of Eastern Equine Encephalitis Virus From an Organ Donor to 3 Transplant Recipients.
Clin Infect Dis Volume: 69 Page(s): 450 - 458
07/18/2019 Authors: Pouch SM; Katugaha SB; Shieh W-J; Annambhotla P; Walker WL; Basavaraju SV; Jones J; Huynh T; Reagan-Steiner S; Bhatnagar J
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study.
Lancet Haematol Volume: 5 Page(s): e609 - e617
12/01/2018 Authors: Dunleavy K; Fanale MA; Abramson JS; Noy A; Caimi PF; Pittaluga S; Parekh S; Lacasce A; Hayslip JW; Jagadeesh D
Chlamydia: A Rare Cause of Ascites
Volume: 113 Page(s): S1331 - S1331
10/01/2018 Authors: Obineme C; Parekh S; Halford B; Liu D; Piazza M
HIV and Autoimmune Hepatitis: A Case Series and Literature Review
Volume: 112 Page(s): S1222 - S1222
10/01/2017 Authors: Spiritos Z; Reynolds P; Parekh S; Perricone A; Quigley B
Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin.
Aliment Pharmacol Ther Volume: 45 Page(s): 1427 - 1432
06/01/2017 Authors: Pillai AA; Maheshwari R; Vora R; Norvell JP; Ford R; Parekh S; Cheng N; Patel A; Young N; Spivey JR
Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Cardiovasc Intervent Radiol Volume: 40 Page(s): 410 - 420
03/01/2017 Authors: Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
Klinefelter's Syndrome-Associated Alpha-1 Antitrypsin Cholestatic Phenotype: A Genetic Linkage Between Two Congenital Diseases
Volume: 111 Page(s): S955 - S956
10/01/2016 Authors: Wehbeh A; Mekaroonkamol P; Quigley BC; Subramanian R; Parekh S
Large Single-Center Experience of Sofosbuvir and Ledipasvir Therapy for the Treatment of Post-Liver Transplant Patients with Hepatitis C Virus.
Volume: 16 Page(s): 298 - 298
06/01/2016 Authors: Wedd J; Ford R; Norvell J; Parekh S; Cheng N; Young N; Patel A; Maheshwari R; Vora R; Mgbemena O
Correlation of Biliary Tract Pathology Identified on Liver Biopsy in Post Liver Transplant Patients With Cholangiographic Findings on Endoscopic Retrograde Cholangiopancreatography (ERCP)
Volume: 83 Page(s): AB607 - AB607
05/01/2016 Authors: Dacha S; Cai Q; Willingham FF; Parekh S; Adams AB; Keilin S
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor- and-, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
Gastroenterology Volume: 150 Page(s): 1147 - 1159.e5
05/01/2016 Authors: Ratziu V; Harrison SA; Francque S; Bedossa P; Lehert P; Serfaty L; Romero-Gomez M; Boursier J; Abdelmalek M; Caldwell S
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
Am J Gastroenterol Volume: 111 Page(s): 250 - 260
02/01/2016 Authors: Pillai AA; Wedd J; Norvell JP; Parekh S; Cheng N; Young N; Spivey JR; Ford R
LARGE SINGLE CENTER EXPERIENCE OF SOFOSBUVIR AND LEDIPASVIR THERAPY FOR THE TREATMENT OF PATIENTS WITH HEPATITIS C VIRUS
Volume: 64 Page(s): S780 - S780
01/01/2016 Authors: Wedd J; Ford R; Norvell J; Parekh S; Cheng N; Young N; Patel A; Maheshwari R; Vora R; Mgbemena O
Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.
Brain Behav Immun Volume: 46 Page(s): 17 - 22
05/01/2015 Authors: Haroon E; Felger JC; Woolwine BJ; Chen X; Parekh S; Spivey JR; Hu XP; Miller AH
Treatment of Patients with Chronic Genotype 1 Hepatitis C With a Combination of Sofosbuvir, Simeprevir, plus /- Ribavirin at a High-Volume Academic Transplant Center
Volume: 109 Page(s): S180 - S181
10/01/2014 Authors: Pillai A; Ford R; Cheng N; Shah A; Norvell J; Laurence S; Young N; Parekh S; Spivey J
Recurrent Disease after Liver Transplantation
Page(s): 869 - 882
01/01/2014 Authors: Parekh S; Spivey JR
Post-Liver Transplant Treatment of Hepatitis C with a combination of Sofosbuvir, Simeprevir, +/- Ribavirin at a High Volume Academic Transplant Center
Volume: 60 Page(s): 701A - 701A
01/01/2014 Authors: Ford RM; Pillai A; Cheng N; Young NM; Parekh S; Norvell JP; Subramanian R; Spivey J
More on hepatocellular carcinoma after the Fontan procedure.
N Engl J Med Volume: 369 Page(s): 490
08/01/2013 Authors: Elder RW; Parekh S; Book WM
Outcomes following renal transplantation in patients with chronic hepatitis C based on severity of fibrosis on pre-transplant liver biopsy.
Saudi J Kidney Dis Transpl Volume: 24 Page(s): 682 - 687
07/01/2013 Authors: Dbouk N; Parekh S
Is non-alcoholic steatohepatitis a predisposing factor to porphyria cutanea tarda?
Photodermatol Photoimmunol Photomed Volume: 29 Page(s): 106 - 108
04/01/2013 Authors: Ergen EN; Seidler E; Parekh S; Parker SRS
Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients.
J Gastroenterol Hepatol Volume: 28 Page(s): 537 - 542
03/01/2013 Authors: Dbouk N; Parekh S
Management of alcoholic hepatitis: Current concepts.
World J Hepatol Volume: 4 Page(s): 335 - 341
12/27/2012 Authors: Karsan HA; Parekh S
A Very Rare Case of Autoimmune Hepatitis in a Patient with HIV
AMERICAN JOURNAL OF GASTROENTEROLOGY Volume: 107 Page(s): S411 - S411
10/01/2012 Authors: Whitfield T; Shahnavaz N; Parekh S; Cohen R
Weissella confusa bacteremia in a liver transplant patient with hepatic artery thrombosis.
Transpl Infect Dis Volume: 13 Page(s): 290 - 293
06/01/2011 Authors: Harlan NP; Kempker RR; Parekh SM; Burd EM; Kuhar DT
Predominant ataxia, low ceruloplasmin, and absent K-F rings: hypoceruloplasminemia or Wilson's disease.
Mov Disord Volume: 25 Page(s): 2260 - 2261
10/15/2010 Authors: Mehta SH; Parekh SM; Prakash R; Morgan JC; Miyajima H; Sethi KD
IMPACT OF PRE TRANSPLANT ANA AND ASMA LEVELS ON RECURRENCE RATES AND GRAFT SURVIVAL POST OLT IN AIH PATIENTS
Volume: 52 Page(s): 859A - 859A
10/01/2010 Authors: Dbouk N; Parekh S
MRI TO PRIMARILY SCREEN FOR ESOPHAGEAL VARICES IN NON-BLEEDING PATIENTS WITH CIRRHOSIS/PORTAL HYPERTENSION: A SINGLE CENTER EXPERIENCE
Volume: 52 Page(s): 1080A - 1080A
10/01/2010 Authors: Lom J; Parekh S; Martin DR; Spivey J; Ford RM; Kalb B
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.
Blood Volume: 116 Page(s): 1025 - 1034
08/19/2010 Authors: Leshchenko VV; Kuo P-Y; Shaknovich R; Yang DT; Gellen T; Petrich A; Yu Y; Remache Y; Weniger MA; Rafiq S
Coexisting hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation.
J Clin Gastroenterol Volume: 44 Page(s): e136 - e140
08/01/2010 Authors: Pham DM; Subramanian R; Parekh S
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
J Vasc Interv Radiol Volume: 21 Page(s): 1197 - 1204
08/01/2010 Authors: Dhanasekaran R; Khanna V; Kooby DA; Spivey JR; Parekh S; Knechtle SJ; Carew JD; Kauh JS; Kim HS
Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Am J Gastroenterol Volume: 105 Page(s): 635 - 641
03/01/2010 Authors: Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Biliary Obstruction After Orthotopic Liver Retransplantation Secondary to Bile Duct Traumatic Neuroma
Volume: 104 Page(s): S291 - S291
10/01/2009 Authors: Lammert C; Parekh S; Keilen S
LOCOREGIONAL THERAPIES AS A BRIDGE TO TRANSPLANT IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Volume: 50 Page(s): 1104A - 1104A
10/01/2009 Authors: Sakaria SS; Dhanasekaran R; Pankonin M; Parekh S; Kim HS
PREDICTORS OF EARLY MORTALITY AFTER TRAN-SJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTS (TIPS)
Volume: 50 Page(s): 436A - 437A
10/01/2009 Authors: Dhanasekaran R; Gonzales PC; West J; Subramanian R; Parekh S; Spivey JR; Reshamwala P; Martin LG; Kim HS
OUTCOMES FOLLOWING RENAL TRANSPLANTATION IN PATIENTS WITH CHRONIC HEPATITIS C BASED ON SEVERITY OF FIBROSIS ON PRE TRANSPLANT LIVER BIOPSY
Volume: 50 Page(s): 919A - 919A
10/01/2009 Authors: Dbouk N; Parekh S
Locoregional therapies as a bridge to transplant in patients with hepatocellular carcinoma
Volume: 27
05/20/2009 Authors: Sakaria SS; Dhanasekaran R; Pankonin M; Parekh S; Kauh JS; Kim HS
Locoregional therapies as a bridge to transplant in patients with hepatocellular carcinoma.
J Clin Oncol Volume: 27 Page(s): e15608
05/20/2009 Authors: Sakaria SS; Dhanasekaran R; Pankonin M; Parekh S; Kauh JS; Kim HS
Factors associated with low platelet count in veterans with chronic hepatitis C
Volume: 102 Page(s): S233 - S233
09/01/2007 Authors: Parekh S; Simpson A; Wehbi M; Shaukat A; Obideen K
Statins and hepatitis C therapy: A retrospective analysis in a veteran medical center
Volume: 102 Page(s): S232 - S233
09/01/2007 Authors: Simpson A; Obideen K; Parekh S; Sonali S; Minal P; Chacko K; Wehbi M
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Gastroenterology Volume: 132 Page(s): 2191 - 2207
05/01/2007 Authors: Parekh S; Anania FA
Does gallbladder pathology predict reoccurrence of symptoms post cholecystectomy? A telephone survey of patients with cholecystectomy
Volume: 101 Page(s): S115 - S115
09/01/2006 Authors: Okoro N; Patel A; Parekh S; Han Y; Cai Q
Clinical significance of isolated intrahepatic ductal dilatation detected by computed tomography
Volume: 101 Page(s): S114 - S114
09/01/2006 Authors: Parekh S; Okoro N; Patel A; Han Y; Cai Q
Isolated main pancreatic ductal dilatation detected by computed tomography: When to be concerned for malignancy?
Volume: 101 Page(s): S114 - S115
09/01/2006 Authors: Patel A; Okoro N; Parekh S; Han Y; Cai Q
The Diabetes Prevention Program and the metabolic syndrome.
Ann Intern Med Volume: 143 Page(s): 545
10/04/2005 Authors: Anania FA; Parekh S; Shaukat A

Directory section navigation

Profile